EP3996679
HIGH CONCENTRATION INSULIN FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.7.2020EP published:
6.9.2023EP application number:
20739655.7
EPO information:
European Patent Register
Max expiry date:
9.7.2040
Title in English:
HIGH CONCENTRATION INSULIN FORMULATIONLanguage of the patent:
English
Timeline
Today
10.7.2020EP application
6.9.2023EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
STURIS, JeppeAddress:
2880 Bagsværd, DK
Name:
HAVELUND, SvendAddress:
2880 Bagsværd, DK
Name:
PEDERSEN, Karen-MargretheAddress:
2880 Bagsværd, DK
Priority
Number:
19185958Date:
12.7.2019Country:
EP
Classification
Categories:
A61K 9/08, A61K 38/28, A61K 47/02, A61K 47/12, A61K 47/18, A61P 3/10